Enterprise Prods Partners L Com (EPD) Holder Summit Equities Trimmed Holding by $134.96 Million; Clark Estates Has Decreased Its Pfizer (PFE) Position by $10.80 Million; Stock Price Declined

April 17, 2018 - By Darrin Black

Enterprise Products Partners L.P. (NYSE:EPD) Logo

Summit Equities Inc decreased its stake in Enterprise Prods Partners L Com (EPD) by 13.03% based on its latest 2017Q4 regulatory filing with the SEC. Summit Equities Inc sold 5,091 shares as the company’s stock declined 8.22% with the market. The institutional investor held 33,972 shares of the natural gas distribution company at the end of 2017Q4, valued at $900.61 million, down from 39,063 at the end of the previous reported quarter. Summit Equities Inc who had been investing in Enterprise Prods Partners L Com for a number of months, seems to be less bullish one the $58.98B market cap company. The stock increased 1.24% or $0.33 during the last trading session, reaching $27.16. About 3.69 million shares traded. Enterprise Products Partners L.P. (NYSE:EPD) has declined 10.03% since April 17, 2017 and is downtrending. It has underperformed by 21.58% the S&P500.

Clark Estates Inc decreased its stake in Pfizer Inc (PFE) by 18.29% based on its latest 2017Q4 regulatory filing with the SEC. Clark Estates Inc sold 300,000 shares as the company’s stock declined 3.13% with the market. The institutional investor held 1.34M shares of the health care company at the end of 2017Q4, valued at $48.55M, down from 1.64 million at the end of the previous reported quarter. Clark Estates Inc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $216.20 billion market cap company. The stock decreased 0.51% or $0.18 during the last trading session, reaching $36.35. About 6.51 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since April 17, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Among 26 analysts covering Enterprise Products Partners LP (NYSE:EPD), 26 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Enterprise Products Partners LP had 56 analyst reports since July 23, 2015 according to SRatingsIntel. The stock of Enterprise Products Partners L.P. (NYSE:EPD) has “Overweight” rating given on Tuesday, January 31 by Barclays Capital. BMO Capital Markets maintained the stock with “Buy” rating in Monday, November 13 report. The company was initiated on Thursday, July 23 by DA Davidson. The firm has “Buy” rating given on Tuesday, August 15 by BMO Capital Markets. On Thursday, August 10 the stock rating was maintained by Stifel Nicolaus with “Buy”. The stock of Enterprise Products Partners L.P. (NYSE:EPD) has “Buy” rating given on Thursday, March 8 by Seaport Global. The company was maintained on Thursday, September 14 by Stifel Nicolaus. Jefferies maintained Enterprise Products Partners L.P. (NYSE:EPD) rating on Thursday, August 3. Jefferies has “Buy” rating and $3300 target. On Friday, April 1 the stock rating was reinitiated by Piper Jaffray with “Overweight”. Jefferies maintained Enterprise Products Partners L.P. (NYSE:EPD) rating on Thursday, June 22. Jefferies has “Buy” rating and $3300 target.

Investors sentiment decreased to 0.85 in Q4 2017. Its down 0.15, from 1 in 2017Q3. It turned negative, as 60 investors sold EPD shares while 283 reduced holdings. 73 funds opened positions while 219 raised stakes. 750.14 million shares or 4.26% less from 783.53 million shares in 2017Q3 were reported. Stratos Wealth Ptnrs, a Ohio-based fund reported 95,201 shares. Gould Asset Management Limited Liability Company Ca reported 18,316 shares. Grandfield & Dodd Ltd has 10,496 shares for 0.03% of their portfolio. Ironsides Asset holds 41,205 shares. Barnett And reported 33,321 shares stake. Kornitzer Cap Mgmt Incorporated Ks invested in 0.01% or 23,950 shares. Princeton Portfolio Strategies Gru Limited Liability Corp reported 70,873 shares. Walleye Trading Ltd Liability Corp owns 0.01% invested in Enterprise Products Partners L.P. (NYSE:EPD) for 46,352 shares. Tnb Fin has 0.29% invested in Enterprise Products Partners L.P. (NYSE:EPD) for 58,567 shares. Adell Harriman And Carpenter invested in 400,048 shares. Green Square Capital Lc has invested 1.53% in Enterprise Products Partners L.P. (NYSE:EPD). Riverpoint Capital Mngmt holds 0.39% of its portfolio in Enterprise Products Partners L.P. (NYSE:EPD) for 244,431 shares. Chickasaw Cap Mgmt Ltd Limited Liability Company has 7.74% invested in Enterprise Products Partners L.P. (NYSE:EPD) for 13.99 million shares. Wealthtrust Axiom Lc has 0.31% invested in Enterprise Products Partners L.P. (NYSE:EPD) for 31,326 shares. Blackhill Capital Inc has 0.81% invested in Enterprise Products Partners L.P. (NYSE:EPD).

Summit Equities Inc, which manages about $2.45 billion and $586.64 billion US Long portfolio, upped its stake in United Sts Commodity Index Fd (USCI) by 10,474 shares to 430,770 shares, valued at $18.32B in 2017Q4, according to the filing. It also increased its holding in Ishares Core Total Usd Bond Mkt (IUSB) by 12,935 shares in the quarter, for a total of 63,512 shares, and has risen its stake in Ishares National Mun Etf (MUB).

Since March 7, 2018, it had 2 insider buys, and 0 insider sales for $1.10 million activity.

Analysts await Enterprise Products Partners L.P. (NYSE:EPD) to report earnings on April, 30 before the open. They expect $0.37 earnings per share, up 2.78% or $0.01 from last year’s $0.36 per share. EPD’s profit will be $803.51 million for 18.35 P/E if the $0.37 EPS becomes a reality. After $0.37 actual earnings per share reported by Enterprise Products Partners L.P. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1 before the open. They expect $0.73 earnings per share, up 5.80% or $0.04 from last year’s $0.69 per share. PFE’s profit will be $4.34B for 12.45 P/E if the $0.73 EPS becomes a reality. After $0.62 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 17.74% EPS growth.

Investors sentiment increased to 1.06 in Q4 2017. Its up 0.10, from 0.96 in 2017Q3. It improved, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. Bbva Compass Bankshares Incorporated holds 374,270 shares or 0.86% of its portfolio. 33,725 are owned by Hoertkorn Richard Charles. Keybank Natl Association Oh reported 0.84% stake. Silvercrest Asset Mngmt Grp Ltd Liability reported 3.27 million shares. Premier Asset Mgmt Ltd invested 0.32% of its portfolio in Pfizer Inc. (NYSE:PFE). Foundation Res Management invested 8.19% in Pfizer Inc. (NYSE:PFE). Ngam Advisors LP invested 0.54% in Pfizer Inc. (NYSE:PFE). Fairfax Can, a Ontario – Canada-based fund reported 210,000 shares. 246,915 were accumulated by Jones Collombin Inv Counsel. Btr Cap Mgmt holds 252,988 shares. American Asset Management holds 0.57% of its portfolio in Pfizer Inc. (NYSE:PFE) for 26,148 shares. Panagora Asset Mgmt accumulated 0.28% or 2.06 million shares. Fund Mngmt reported 444,322 shares. Insight 2811 holds 35,058 shares or 0.93% of its portfolio. Sfmg Lc accumulated 7,249 shares or 0.04% of the stock.

Since December 15, 2017, it had 0 buys, and 12 insider sales for $12.99 million activity. On Tuesday, March 13 the insider JOHNSON RADY A sold $998,666. LUND-JURGENSEN KIRSTEN also sold $353,677 worth of Pfizer Inc. (NYSE:PFE) shares. On Wednesday, February 28 HILL CHARLES H sold $986,292 worth of Pfizer Inc. (NYSE:PFE) or 26,779 shares. MACKENZIE ALEXANDER R also sold $249,750 worth of Pfizer Inc. (NYSE:PFE) shares. SUSMAN SALLY sold $1.24 million worth of Pfizer Inc. (NYSE:PFE) on Monday, February 26. Shares for $1.84M were sold by LANKLER DOUGLAS M on Tuesday, March 13.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: